Sushil Patel
Chief Executive Officer presso REPLIMUNE GROUP, INC.
Patrimonio netto: 2 M $ in data 30/04/2024
Posizioni attive di Sushil Patel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Director/Board Member | 01/04/2024 | - |
| Chief Executive Officer | 01/04/2024 | - | |
| Public Communications Contact | 03/05/2021 | 03/01/2023 | |
| Corporate Officer/Principal | 03/01/2023 | 01/04/2024 | |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 16/06/2022 | - |
| Independent Dir/Board Member | 16/06/2022 | - |
Storia della carriera di Sushil Patel
Precedenti posizioni note di Sushil Patel
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2008 | 01/05/2021 |
Formazione di Sushil Patel
| Imperial College London | Graduate Degree |
| University of London | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Graduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REVOLUTION MEDICINES, INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Sushil Patel
- Esperienza
